- CDK inhibitors in cancer therapy: what is next?
[作者:Malumbres, M; Pevarello, P; Barbacid, M; Bischoff, JR,期刊:Trends in Pharmacological Sciences, 页码:16-21 , 文章类型: Review,,卷期:2008年29-1]
The pursuit for drugs that inhibit cyclin-dependent kinases (CDKs) has been an intense area of research for more than 15 years. The first-generation inhibitors, Flavopiridol and CY-202, are in late-stage clinical tria...
|